Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
Extramedullary manifestations (EM) are rare in acute myeloid leukemia (AML) and their impact on clinical outcomes is controversially discussed.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2022
|
| In: |
Journal of hematology & oncology
Year: 2022, Volume: 15, Pages: 1-13 |
| ISSN: | 1756-8722 |
| DOI: | 10.1186/s13045-022-01267-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13045-022-01267-7 |
| Author Notes: | Jan-Niklas Eckardt, Friedrich Stölzel, Desiree Kunadt, Christoph Röllig, Sebastian Stasik, Lisa Wagenführ, Korinna Jöhrens, Friederike Kuithan, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W. Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Frank Kroschinsky, Wolfgang E. Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D. Baldus, Johannes Schetelig, Martin Bornhäuser, Christian Thiede and Jan Moritz Middeke |
| Summary: | Extramedullary manifestations (EM) are rare in acute myeloid leukemia (AML) and their impact on clinical outcomes is controversially discussed. |
|---|---|
| Item Description: | Published: 13 May 2022 Gesehen am 28.06.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1756-8722 |
| DOI: | 10.1186/s13045-022-01267-7 |